OSA patients not treated with PAP - evolution 5 years ahead according to Baveno classification
M. Serino (Porto, Portugal), C. Cardoso (Porto, Portugal), R. Cordeiro (Torres Vedras, Portugal), J. Ferra (Lisboa, Portugal), F. Aguiar (Braga, Portugal), D. Rodrigues (Porto, Portugal), M. Redondo (Porto, Portugal), M. Van Zeller (Porto, Portugal), M. Drummond (Porto, Portugal)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Serino (Porto, Portugal), C. Cardoso (Porto, Portugal), R. Cordeiro (Torres Vedras, Portugal), J. Ferra (Lisboa, Portugal), F. Aguiar (Braga, Portugal), D. Rodrigues (Porto, Portugal), M. Redondo (Porto, Portugal), M. Van Zeller (Porto, Portugal), M. Drummond (Porto, Portugal). OSA patients not treated with PAP - evolution 5 years ahead according to Baveno classification. 2486
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care Year: 2013
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016
GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality? Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD Year: 2014
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Symptomatic assessment in COPD GOLD 2011 classification - mMRC/CAT agreement Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care Year: 2016
Obstructive sleep-disordered breathing in children 2-18 years old: indications for treatment, stepwise treatment approach and recognition and management of persistent disease Source: International Congress 2015 – Obstructive sleep apnoea in adults and children Year: 2015
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations? Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018
Survival in three years of COPD patients according to GOLD 2003 and GOLD 2014 Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015
What clinical features underlying GINA step 1-4 drive the level of treatment in patients with asthma Source: Eur Respir J 2001; 18: Suppl. 33, 57s Year: 2001
Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016
Prediction of the clinical course of COPD using the old and the new GOLD classification Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
The BODE index predicts mortality better than 2007 GOLD and GOLD ABCD Source: International Congress 2014 – COPD exacerbations Year: 2014
Chronic obstructive pulmonary disease in 55 years old women from Germany according to GOLD stages Source: Eur Respir J 2004; 24: Suppl. 48, 359s Year: 2004
The current ERS, BTS, ATS and GOLD classification criteria underestimate the impact of COPD on patients Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002
Prevalence of comorbidities in established and newly treated patients with COPD according to GOLD 2017 in a UK primary care population Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Relation of various parameters to the survival rate in stage 0 to stage IIa chronic obstructive pulmonary disease (COPD) according to the GOLD guidelines Source: Eur Respir J 2003; 22: Suppl. 45, 578s Year: 2003
High risk COPD patients cost less if treated according to GOLD 2011 recommendations Source: Annual Congress 2013 –COPD diagnosis Year: 2013
More than half of patients with COPD in Poland are still smoking, only one third is treated according to GOLD recommendations – Results from PulmoScreen study Source: Annual Congress 2010 - Therapy and health economics of asthma and COPD Year: 2010
Combined assessment according to the new GOLD guidelines and its relation to outcome in COPD Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD Year: 2012
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) Source: Eur Respir J , 49 (3) 1501885; DOI: 10.1183/13993003.01885-2015 Year: 2017